Treatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalEtoposideBreast NeoplasmsNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmBleomycinNeoplasmsDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungFollow-Up StudiesOvarian NeoplasmsNeoplasm MetastasisTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousAdenocarcinomaNauseaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseTime FactorsColorectal NeoplasmsRadiotherapyAntibiotics, AntineoplasticDacarbazineClinical Trials as TopicProspective StudiesNeoplasms, Germ Cell and EmbryonalCarmustineLomustineGranulocyte Colony-Stimulating FactorCamptothecinKaplan-Meier EstimatePlatinum CompoundsBrain NeoplasmsBone NeoplasmsInfusions, Intra-ArterialOsteosarcomaMelphalanLeukopeniaAntiemeticsMitomycinThiotepaTumor Markers, BiologicalLiver NeoplasmsHematopoietic Stem Cell TransplantationDrug TherapyPeritoneal NeoplasmsMitoxantroneInfusions, IntravenousLymphatic MetastasisRecurrenceStomach NeoplasmsDose-Response Relationship, DrugTegafurPalliative CareAntibodies, Monoclonal, HumanizedGerminomaRadiotherapy DosageCell Line, TumorDaunorubicinCarcinoma, Squamous CellCarcinomaPrecursor Cell Lymphoblastic Leukemia-LymphomaRandomized Controlled Trials as TopicDisease ProgressionLeukemia, Myeloid, AcuteLymphomaBridged Compounds